Welcome to Dwaey, specifically on Clarithromycin + Metronidazole + Lansoprazol page.
This medicine contains important and useful components, as it consists of
Clarithromycin + Metronidazole + Lansoprazol is available in the market in concentration.
Clarithromycin + Metronidazole + Lansoprazol
Before using Clarithromycin + Metronidazole + Lansoprazole, it is crucial to consult a healthcare provider, particularly for individuals with the following conditions:
- Allergies: This combination may cause allergic reactions, particularly to any of the ingredients—Clarithromycin, Metronidazole, or Lansoprazole. Symptoms of an allergic reaction may include rash, itching, swelling, or difficulty breathing.
- Liver Impairment: This combination includes Clarithromycin, which is metabolized in the liver. Caution is needed in individuals with liver disease (such as cirrhosis or hepatitis). Liver function should be monitored regularly.
- Renal Impairment: Caution should be exercised in patients with impaired kidney function, as both Clarithromycin and Metronidazole are eliminated by the kidneys. Dosage adjustments may be necessary.
- Prolonged Use: Prolonged use of Metronidazole and Clarithromycin may lead to the development of resistant bacteria, reducing the effectiveness of these drugs.
- Pregnancy and Breastfeeding: This combination should be used during pregnancy only if clearly needed. Metronidazole and Clarithromycin are classified as Category C (risk cannot be ruled out), and Lansoprazole is a Category B drug (no risk in animal studies, but safety has not been established in humans). Pregnant women or those breastfeeding should consult their doctor before using this combination.
- Drug Interactions: This combination may interact with other medications, such as warfarin, benzodiazepines, and antacids, and may require dose adjustments or monitoring.
Clarithromycin + Metronidazole + Lansoprazole is commonly prescribed for:
- Helicobacter pylori Eradication: This combination is often used in the treatment of H. pylori infection associated with peptic ulcers. It works by eliminating the bacteria that contribute to ulcer formation.
- Peptic Ulcer Disease: The combination of antibiotics (Clarithromycin and Metronidazole) along with Lansoprazole (a proton pump inhibitor) is used to treat and prevent the recurrence of ulcers caused by H. pylori infections.
- Gastritis: It can also be used for the treatment of gastritis linked to H. pylori infection.
- Infection Prevention: Sometimes, this combination is prescribed to prevent post-surgical infections or infections following medical procedures involving the gastrointestinal tract.
This combination should not be used in the following situations:
- Hypersensitivity: Contraindicated in patients with known hypersensitivity to Clarithromycin, Metronidazole, or Lansoprazole. An allergic reaction can result in rashes, difficulty breathing, and anaphylaxis.
- Severe Liver Disease: Patients with severe liver dysfunction or hepatic failure should avoid using this combination, especially Clarithromycin, which is metabolized in the liver.
- Pregnancy: The combination should not be used during pregnancy unless absolutely necessary. Particularly Metronidazole has been linked to potential fetal harm in animal studies, though its effects on human pregnancy are not fully understood.
- Severe Renal Impairment: In patients with severe renal dysfunction, the combination should be used with caution, as it may affect the clearance of Clarithromycin and Metronidazole. Dose adjustment may be required.
- QT Prolongation: Clarithromycin can prolong the QT interval and may lead to arrhythmias. It is contraindicated in patients with QT prolongation or those taking medications that affect the QT interval.
- Concomitant Use with Certain Drugs: This combination should not be used with medications that interact with any of its components, such as ergotamine or cisapride, as these interactions can cause serious side effects like serotonin syndrome or heart arrhythmias.
The combination of Clarithromycin + Metronidazole + Lansoprazole may cause the following side effects:
- Common Side Effects:
- Gastrointestinal issues: Nausea, vomiting, diarrhea, and abdominal discomfort.
- Headache or dizziness, especially with Metronidazole.
- Taste disturbances (metallic or bitter taste) from Metronidazole.
- Skin rash or itching from Clarithromycin.
- Serious Side Effects:
- Allergic Reactions: Severe allergic reactions including anaphylaxis (difficulty breathing, swelling of the face and throat) may occur.
- Liver Toxicity: Elevated liver enzymes and liver dysfunction, especially in those with pre-existing liver conditions.
- Severe Gastrointestinal Issues: Prolonged diarrhea (possibly caused by Clostridium difficile infection), especially if diarrhea is watery or bloody.
- Cardiac Issues: Clarithromycin may cause prolonged QT interval, leading to arrhythmias or irregular heartbeats, which can be dangerous.
- Peripheral Neuropathy: Long-term use of Metronidazole may cause nerve damage, leading to numbness or tingling in the hands or feet.
Patients should contact their healthcare provider immediately if any of these severe side effects occur.
- Clarithromycin: A macrolide antibiotic, clarithromycin works by inhibiting bacterial protein synthesis through binding to the 50S ribosomal subunit, thus preventing bacterial growth and replication. It is effective against a broad range of bacteria, including H. pylori.
- Metronidazole: An antiprotozoal and antibiotic, metronidazole works by entering the bacteria’s cell and disrupting its DNA synthesis. It is particularly effective against anaerobic bacteria and protozoa like Giardia and Entamoeba histolytica, as well as H. pylori.
- Lansoprazole: As a proton pump inhibitor (PPI), lansoprazole inhibits the H+/K+ ATPase pump in the stomach lining, reducing the production of gastric acid. This helps heal ulcers and prevents further damage from stomach acid, especially in combination with antibiotics.
Together, these three medications work synergistically to eradicate H. pylori, heal ulcers, and manage acid-related gastrointestinal issues.
Clarithromycin + Metronidazole + Lansoprazole can interact with several drugs:
- Clarithromycin Interactions:
- Warfarin: Increased bleeding risk due to interaction with Clarithromycin. Monitor prothrombin time and adjust warfarin dose if needed.
- Statins (e.g., Simvastatin): Increased risk of muscle toxicity when taken with Clarithromycin. Dose reduction of statins may be necessary.
- CYP3A4 Inhibitors: Clarithromycin inhibits CYP3A4, potentially altering the metabolism of drugs like benzodiazepines, theophylline, and certain immunosuppressants. Close monitoring is required when combined with these drugs.
- Metronidazole Interactions:
- Alcohol: Metronidazole can cause a disulfiram-like reaction with alcohol, leading to severe nausea, vomiting, and headaches.
- Warfarin: Increased anticoagulant effect and bleeding risk. Regular monitoring of INR is recommended.
- Lithium: May increase lithium toxicity. Monitor lithium levels carefully.
- Lansoprazole Interactions:
- Antacids: Lansoprazole may interact with antacids, decreasing its effectiveness if taken simultaneously. If both medications are needed, take Lansoprazole first, followed by the antacid.
- Diazepam and other sedatives: Lansoprazole can increase the blood levels of these medications, increasing their sedative effects.
- Clopidogrel: Lansoprazole may reduce the effectiveness of clopidogrel, which is used to prevent blood clots. Caution is advised when using both medications together.
The typical adult dose for this combination is:
- Clarithromycin: 500 mg twice daily.
- Metronidazole: 500 mg twice daily.
- Lansoprazole: 30 mg once daily.
This treatment is generally prescribed for 10–14 days for the eradication of H. pylori and the treatment of peptic ulcers.
This combination is generally not recommended for children, especially younger than 12 years of age, unless prescribed by a healthcare provider for specific conditions. Pediatric doses would be adjusted based on body weight and clinical condition, but careful monitoring is required to ensure safe and effective use. Always consult a healthcare provider for appropriate dosing in children.
In patients with renal impairment, dose adjustments are necessary for Metronidazole and Clarithromycin:
- Metronidazole: In severe renal impairment (creatinine clearance <10 mL/min), the dose should be reduced. It is not recommended in patients with end-stage renal disease.
- Clarithromycin: In moderate to severe renal impairment, the dose of Clarithromycin should be reduced by 50%.
Not available in a medicine form yet